David Nierengarten
Stock Analyst at Wedbush
(4.89)
# 295
Out of 4,675 analysts
578
Total ratings
55.1%
Success rate
23.7%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding | Maintained: Buy | $50 → $64 | $58.20 | +9.97% | 16 | Aug 21, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $35 | $25.98 | +34.72% | 1 | Aug 19, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $16 → $9 | $3.74 | +140.64% | 7 | Aug 18, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,050 → $1,150 | $1,011.11 | +13.74% | 60 | Aug 18, 2026 | |
| ZBIO Zenas BioPharma | Maintained: Buy | $45 | $31.65 | +42.18% | 4 | Aug 14, 2026 | |
| STTK Shattuck Labs | Maintained: Buy | $11 | $7.90 | +39.24% | 4 | Aug 12, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $55 → $64 | $46.67 | +37.13% | 4 | Aug 12, 2026 | |
| ORKA Oruka Therapeutics | Initiated Coverage: Buy | $165 | $102.42 | +61.10% | 9 | Aug 11, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $130 | $106.65 | +21.89% | 11 | Aug 11, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $55 | $36.23 | +51.81% | 22 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 | $80.94 | +8.72% | 22 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $30.31 | +31.97% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $135 | $134.79 | +0.16% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $30 | $29.00 | +3.47% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $28.33 | +129.44% | 19 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $25.15 | +19.28% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.19 | +244.83% | 14 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $99 | $79.38 | +24.72% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $20 | $16.76 | +19.33% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.76 | +62.72% | 28 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 → $140 | $116.15 | +20.53% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.7993 | +525.55% | 6 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $60 | $20.49 | +192.83% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $9.14 | +173.52% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $58.44 | +28.34% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $44.72 | -28.44% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $11.52 | +99.65% | 5 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $13.46 | +48.59% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | kr 41.84 | +64.91% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $35 | $25.72 | +36.08% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $22.71 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $23.58 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.44 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $28.01 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $5.62 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.25 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $4 | $1.86 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $36.47 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $110.07 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $11.40 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $68 → $53 | $12.56 | n/a | 14 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $32 | $4.02 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €303.05 → €297.91 | €869.80 | n/a | 2 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $10 | $0.0001 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $36 | $3.44 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $642.63 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $13 | $9.39 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $12.40 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.18 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $4.13 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.000001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.03 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $40.57 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $0.8015 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $123.98 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $26.49 | n/a | 1 | Mar 22, 2013 |
Scholar Rock Holding
Aug 21, 2026
Maintained: Buy
Price Target: $50 → $64
Current: $58.20
Upside: +9.97%
Aktis Oncology
Aug 19, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $25.98
Upside: +34.72%
Ardelyx
Aug 18, 2026
Maintained: Buy
Price Target: $16 → $9
Current: $3.74
Upside: +140.64%
argenx SE
Aug 18, 2026
Maintained: Buy
Price Target: $1,050 → $1,150
Current: $1,011.11
Upside: +13.74%
Zenas BioPharma
Aug 14, 2026
Maintained: Buy
Price Target: $45
Current: $31.65
Upside: +42.18%
Shattuck Labs
Aug 12, 2026
Maintained: Buy
Price Target: $11
Current: $7.90
Upside: +39.24%
Hemab Therapeutics Holdings
Aug 12, 2026
Maintained: Buy
Price Target: $55 → $64
Current: $46.67
Upside: +37.13%
Oruka Therapeutics
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $165
Current: $102.42
Upside: +61.10%
Spyre Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $130
Current: $106.65
Upside: +21.89%
Cogent Biosciences
Aug 11, 2026
Maintained: Buy
Price Target: $55
Current: $36.23
Upside: +51.81%
Aug 11, 2026
Maintained: Buy
Price Target: $88
Current: $80.94
Upside: +8.72%
Aug 11, 2026
Maintained: Buy
Price Target: $40
Current: $30.31
Upside: +31.97%
Aug 11, 2026
Maintained: Hold
Price Target: $135
Current: $134.79
Upside: +0.16%
Aug 6, 2026
Maintained: Buy
Price Target: $26 → $30
Current: $29.00
Upside: +3.47%
Aug 5, 2026
Maintained: Buy
Price Target: $65
Current: $28.33
Upside: +129.44%
Aug 5, 2026
Maintained: Buy
Price Target: $30
Current: $25.15
Upside: +19.28%
Aug 3, 2026
Maintained: Buy
Price Target: $11
Current: $3.19
Upside: +244.83%
Jul 28, 2026
Reiterated: Buy
Price Target: $72 → $99
Current: $79.38
Upside: +24.72%
Jul 24, 2026
Maintained: Hold
Price Target: $18 → $20
Current: $16.76
Upside: +19.33%
Jul 21, 2026
Maintained: Buy
Price Target: $11
Current: $6.76
Upside: +62.72%
Jul 6, 2026
Maintained: Hold
Price Target: $110 → $140
Current: $116.15
Upside: +20.53%
Jun 23, 2026
Maintained: Buy
Price Target: $5
Current: $0.7993
Upside: +525.55%
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $20.49
Upside: +192.83%
May 13, 2026
Maintained: Buy
Price Target: $25
Current: $9.14
Upside: +173.52%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $58.44
Upside: +28.34%
Mar 17, 2026
Maintained: Buy
Price Target: $32
Current: $44.72
Upside: -28.44%
Mar 11, 2026
Maintained: Buy
Price Target: $23
Current: $11.52
Upside: +99.65%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $13.46
Upside: +48.59%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: kr 41.84
Upside: +64.91%
Oct 14, 2025
Maintained: Hold
Price Target: $75 → $35
Current: $25.72
Upside: +36.08%
Jun 26, 2025
Maintained: Hold
Price Target: $8
Current: $22.71
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $23.58
Upside: n/a
May 14, 2025
Maintained: Hold
Price Target: $5
Current: $2.44
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $33
Current: $28.01
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $2
Current: $5.62
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $3.25
Upside: n/a
Jul 26, 2023
Maintained: Hold
Price Target: $9 → $4
Current: $1.86
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $36.47
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $110.07
Upside: n/a
Jan 25, 2023
Maintained: Buy
Price Target: $19 → $17
Current: $11.40
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $68 → $53
Current: $12.56
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $34 → $32
Current: $4.02
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: €303.05 → €297.91
Current: €869.80
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $9 → $10
Current: $0.0001
Upside: n/a
Jun 18, 2019
Maintained: Buy
Price Target: $19 → $36
Current: $3.44
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $642.63
Upside: n/a
Apr 23, 2018
Maintained: Hold
Price Target: $55 → $13
Current: $9.39
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $12.40
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $1.18
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $4.13
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.000001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $1.03
Upside: n/a
May 9, 2016
Maintained: Hold
Price Target: $4 → $3
Current: $40.57
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $0.8015
Upside: n/a
Mar 31, 2014
Maintained: Sell
Price Target: n/a
Current: $123.98
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $26.49
Upside: n/a